Hosted by IDTechEx
Truly Global Daily News Interpreted by Experts
HomeEventsReportsTVCareersAbout UsSign-up or LoginIDTechExTwitterLinkedInGoogle+YoutubeRSSForward To Friend

Pharmaceutical

Nanoparticles breathe new life into doxorubicin cancer treatment

Nanoparticles breathe new life into doxorubicin cancer treatment

Jun 16, 2017 Worldwide
Doxorubicin, originally daunorubicin, is the result of a simultaneous discovery event in the 1950's between researchers in France and Italy. The molecule, a well-known anti-cancer drug used for a variety of indications ranging from acute lymphocytic leukemia to breast cancer, was approved for use in the United States in 1974.